{"DataElement":{"publicId":"2917548","version":"1","preferredName":"Nuclear Karyometry Laboratory Procedure Type","preferredDefinition":"The name that describes the procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.","longName":"N_KRMTRY_LAB_PROC_TP","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2917543","version":"1","preferredName":"Nuclear Karyometry Laboratory Procedure","preferredDefinition":"Information pertaining to the procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.","longName":"NUC_KRYMTRY_LAB_PROC","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2917541","version":"1","preferredName":"Nuclear Karyometry","preferredDefinition":"Pertaining to the nucleus.:Video-microscopy procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.","longName":"C13361:C82399","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nuclear","conceptCode":"C13361","definition":"Pertaining to the nucleus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Karyometry","conceptCode":"C82399","definition":"Video-microscopy procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5948D4-CB43-6A56-E040-BB89AD430FFA","latestVersionIndicator":"Yes","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"ONEDATA","dateModified":"2009-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2486250","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15A9DA1A-D89C-6C6C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-06-07","modifiedBy":"ONEDATA","dateModified":"2006-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5948D4-CB51-6A56-E040-BB89AD430FFA","latestVersionIndicator":"Yes","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2917545","version":"1","preferredName":"Karyometry Test Type","preferredDefinition":"The type of video-microscopy procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.","longName":"KRYMTRY_TST_TP","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Karyometry average nuclear abnormality score","valueDescription":"Karyometry average nuclear abnormality score","ValueMeaning":{"publicId":"2917546","version":"1","preferredName":"Karyometry average nuclear abnormality score","longName":"2917546","preferredDefinition":"Karyometry average nuclear abnormality score","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5948D4-CB92-6A56-E040-BB89AD430FFA","latestVersionIndicator":"Yes","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E5948D4-CBAB-6A56-E040-BB89AD430FFA","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"ONEDATA","dateModified":"2009-07-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2917544","version":"1","preferredName":"Karyometry Test Type","preferredDefinition":"Video-microscopy procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:Type; a subdivision of a particular kind of thing.","longName":"C82399:C47891:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Karyometry","conceptCode":"C82399","definition":"Video-microscopy procedure for the analysis of the nuclear chromatin organization status in neoplastic lesions and the detection of nuclear subpopulations on hematoxylin-eosin stained sections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5948D4-CB6D-6A56-E040-BB89AD430FFA","latestVersionIndicator":"Yes","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"ONEDATA","dateModified":"2009-07-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5948D4-CB7E-6A56-E040-BB89AD430FFA","latestVersionIndicator":"Yes","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"MAESKEB","dateModified":"2009-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Test Name","type":"Preferred Question Text","description":"Test Name","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E5948D4-CBBB-6A56-E040-BB89AD430FFA","latestVersionIndicator":"Yes","beginDate":"2009-07-10","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-07-10","modifiedBy":"MAESKEB","dateModified":"2009-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}